These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15657633)

  • 1. A review of prednicarbate (Dermatop).
    Gupta AK; Chow M
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):5-6, 9. PubMed ID: 15657633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednicarbate (Dermatop): profile of a corticosteroid.
    Gupta AK; Chow M
    J Cutan Med Surg; 2004; 8(4):244-7. PubMed ID: 16092003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednicarbate (dermatop): a review.
    Gupta AK; Chow M
    J Drugs Dermatol; 2004; 3(5):553-6. PubMed ID: 15552608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednicarbate emollient cream 0.1% in pediatric patients with atopic dermatitis.
    Moshang T
    Cutis; 2001 Jul; 68(1):63-9. PubMed ID: 11480151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical use of prednicarbate preparations in children].
    Schulz H; Maue R; Meyer-Latzke E
    Z Hautkr; 1986; 61 Suppl 1():41-50. PubMed ID: 2939635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic index makes easier the choice of admissible substances. No fear concerning cortisone].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587199
    [No Abstract]   [Full Text] [Related]  

  • 8. Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.
    de Tiedra A; Mercadal J; Lozano R
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):193-208. PubMed ID: 10169671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allergic contact dermatitis due to prednicarbate].
    Senff H; Kunz R; Köllner A; Kunze J
    Hautarzt; 1991 Jan; 42(1):53-5. PubMed ID: 2010289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis.
    Aliaga A; Rodríguez M; Armijo M; Bravo J; Avila AL; Mascaro JM; Ferrando J; Del Rio R; Lozano R; Balaguer A
    Int J Dermatol; 1996 Feb; 35(2):131-2. PubMed ID: 8850046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Photographic follow-up of the topical use of prednicarbate preparations in inflammatory dermatoses].
    Schulz H
    Z Hautkr; 1986; 61 Suppl 1():51-61. PubMed ID: 3705673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eczema diseases and erythemato-squamous dermatoses of aging skin--studies of the effectiveness and tolerance of Prednicarbate in various vehicles].
    Stary A; Schulz H; Tronnier H
    Z Hautkr; 1989 Nov; 64(11):1010, 1013-4. PubMed ID: 2692325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Spencer CM; Wagstaff AJ
    BioDrugs; 1998 Jan; 9(1):61-86. PubMed ID: 18020557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prednicarbate--the epidermis-corticoid among the topical corticoids].
    Hautarzt; 1998 Apr; 49(4 Suppl):1-16. PubMed ID: 9595306
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Berlin Model. A multicenter study of prednicarbate in various vehicles].
    Albrecht G
    Z Hautkr; 1986; 61 Suppl 1():88-96. PubMed ID: 2939636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
    Lange K; Gysler A; Bader M; Kleuser B; Korting HC; Schäfer-Korting M
    Pharm Res; 1997 Dec; 14(12):1744-9. PubMed ID: 9453063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
    Kerscher MJ; Hart H; Korting HC; Stalleicken D
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis.
    Foelster-Holst R; Nagel F; Zoellner P; Spaeth D
    Dermatology; 2006; 212(1):66-9. PubMed ID: 16319477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prednicarbate and cetirizin dihydrochloride in the treatment of atopic eczema in the acute phase in children].
    Bartosíková L; Frána L; Necas J; Frána P; Dzúrová J; Petrzelková J; Kollár P; Kotolová H
    Ceska Slov Farm; 2001 Jan; 50(1):38-40. PubMed ID: 11242833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atopic dermatitis -- topical therapy: do patients apply much too little?
    Niemeier V; Kupfer J; Schill WB; Gieler U
    J Dermatolog Treat; 2005 Apr; 16(2):95-101. PubMed ID: 16019623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.